Navigation Links
Mylan Settles Its First-to-File Opportunity on Levetiracetam with UCB
Date:10/4/2007

PITTSBURGH, Oct. 4 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into an agreement to settle pending litigation with UCB Societe Anonyme and UCB Pharma Inc. (collectively, UCB) relating to Levetiracetam Tablets, 250mg, 500mg and 750mg, the generic version of UCB's Keppra(R).

Litigation between Mylan and UCB has been pending in the U.S. District Court for the Northern District of Georgia since March 2004. The lawsuit involved U.S. Patent No. 4,943,639, which expires on July 14, 2008.

Pursuant to the settlement, Mylan has the right to market the 250mg, 500mg and 750mg strengths of Levetiracetam Tablets in the United States on Nov. 1, 2008, provided that UCB obtains pediatric exclusivity for Keppra and Mylan's abbreviated new drug application (ANDA) obtains final approval from the Food and Drug Administration (FDA). If granted, pediatric exclusivity relating to the '639 patent would extend to Jan. 14, 2009. Mylan's entry into the market could come sooner than Nov. 1, 2008, if the FDA does not grant UCB pediatric exclusivity. Additional terms of the settlement are confidential, and the agreement is subject to review by the Department of Justice and the Federal Trade Commission.

Levetiracetam Tablets had U.S. sales of approximately $742 million for the 12 months ending June 30, 2007, for these three strengths.

This press release includes statements that constitute "forward-looking statements," including with regard to the settlement agreement and Mylan's entry into the market. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Because such statem
'/>"/>

SOURCE Mylan Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. Equal Opportunity for the Disabled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Norton HealthDay Reporter MONDAY, ... better when newborn intensive care units (NICU) set up private ... new study finds. Researchers at one children,s hospital found ... less distressed when their NICU switched from the traditional "open-bay" ... online Sept. 22 in the journal Pediatrics , add ...
(Date:9/22/2014)... Malaysia today became a founding partner in the Global ... to promoting young talent in science, technology, engineering and ... New York Academy of Sciences (NYAS), Malaysian Prime Minister ... Monday Sept. 22. , With the goal of developing ... countries by 2020, the initiative will create a host ...
(Date:9/22/2014)... two-generation approaches to reducing poverty that help children ... researchers, advocates, and foundations. By combining education and ... to jobs that offer a path out of ... children, these programs aim to improve the life ... new report from the National Center for Children ...
(Date:9/22/2014)... York, New York (PRWEB) September 22, 2014 ... associated with the use of power morcellators ( ... LLP notes a new report detailing the continued ... warnings from federal regulators that specifically discouraged these ... physicians believe that the potential cancer risks associated ...
(Date:9/22/2014)... Pain does not need to rule your life anymore! ... book designed to guide the individual who suffers with chronic ... is written to help the reader who is struggling with ... a pain-free life — a daily “go-to” guide on breaking ... has become an epidemic, with over 100 million Americans suffering ...
Breaking Medicine News(10 mins):Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:A two-generation lens: Current state policies fail to support families with young children 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 4Health News:Naturopathic Doctor Inspires and Guides Those Who Suffer with Chronic Pain, Pointing the Way Back to Pain-free Living 2
... significantly reduce demand? A new study suggests it will. ... of one side of a cigarette pack with a text ... labels, which include graphic images of lung and mouth cancer, ... 404 adult smokers from four states participated in an experimental ...
... Gordon HealthDay Reporter , MONDAY, Aug. 8 (HealthDay ... at home may reach unsafe temperatures by the time a ... in an insulated container with ice packs. A new ... of the food sent from home was at an unsafe ...
... Aug. 8 (HealthDay News) -- Youth sports programs need ... illness, says an updated policy statement from the American ... can safely participate in outdoor sports and activities in ... adults sometimes create situations that are potentially dangerous," Dr. ...
... prostate cancer expect better recovery from the side effects of ... operation, a University of Michigan Comprehensive Cancer Center study finds. ... of men had expected to have better urinary continence and ... before it the exact opposite of what typically happens. ...
... may not be enough to treat symptoms in neonates ... study from Nationwide Children,s Hospital, this is the first ... neonates based on how and what is refluxed. ... in infants at risk of the life-threatening events chronic ...
... the latest issue of Nature , researchers at ... Pennsylvania clarify the role of two proteins key to ... Notch passes off much of its role during T-cell ... required for many aspects of immunity, and understanding how ...
Cached Medicine News:Health News:Study: Graphic warning labels reduce demand for cigarettes 2Health News:Are Kids Brown-Bagging Bacteria? 2Health News:Are Kids Brown-Bagging Bacteria? 3Health News:Kids Can Safely Play Sports in Hot Weather: Experts 2Health News:Men have overly optimistic expectations about recovery from prostate cancer surgery, U-M study finds 2Health News:New study helps clarify symptoms and characteristics of acid reflux in neonates 2Health News:Penn researchers describe key molecule that keeps immune cell development on track 2
(Date:9/22/2014)... 22, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... a phase I clinical trial in patients with ... tolerability, and immunogenicity of INO-3106. This immunotherapy targets ... aerodigestive cancers. Aerodigestive cancers affect the ... parts of the esophagus and windpipe. The unmet ...
(Date:9/22/2014)... 2014  CorMedix Inc. (NYSE MKT: CRMD), a ... products for the prevention and treatment of cardiorenal ... that TUV-SUD and The Medicinal Evaluation Board of ... granted its request for a label expansion for ... approved in July 2013 for use in the ...
(Date:9/22/2014)... , Sept. 22, 2014  Seres Health, a ... to the human microbiome, today announced that it has ... 2014,s Fierce 15 biotechnology companies, designating it as one ... industry.  "Amid a great deal of ... its focus and commitment to practical therapeutic development," says ...
Breaking Medicine Technology:Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3Seres Health Named a "Fierce 15" Biotech Company for 2014 2
... help protect healthcare workers from accidental injury ... procedures. Each BD plastic-coated micro-hematocrit is encased ... that it does not interfere with the ... the sample. The mylar film will keep ...
... 4100, the worlds first large-format ... angiographic imaging, incorporates GEs exclusive ... Digital Detector (41cm X 41 ... resolution imaging across the full ...
... With the GE Innova 2100IQ: See the ... legs. Place interventional devices. Its all enabled ... panel that helps deliver excellent image quality ... Innova family systems installed worldwide, more physicians ...
... CardioSight Service provides clinically valuable, device-derived ... heart failure to help specialty physicians ... symptoms are stable or deteriorating. For ... with a Medtronic InSync Sentry™ CRT-D ...
Medicine Products: